Chicago
Represents private equity firms, family offices, and strategic investors
Advises clients on the structuring and negotiation of leveraged buyouts, mergers, acquisitions, divestitures, joint ventures, and growth equity and venture capital investments
Advises clients on general corporate and governance matters
Practice spans health, life sciences, consumer goods, packaging, IT outsourcing, real estate services, manufacturing, and business services sectors
Counsels clients on complex US and cross-border transactions
Hunter Sharp focuses his practice on complex US and cross-border transactional matters. He leads teams representing private equity firms, family offices, and strategic investors in the structuring and negotiation of leveraged buyouts, mergers, acquisitions, joint ventures, growth equity and venture capital investments, divestitures, and other general corporate and governance matters.
Hunter has experience across a variety of industries, including healthcare, life sciences, basic industries, consumer goods, packaging, IT outsourcing, real estate services, manufacturing, and business services.
Prior to joining McDermott, Hunter served as vice president and assistant general counsel at Newmark Group Inc., a commercial real estate firm. He also worked as an associate at another international law firm.
In every client engagement, he brings an understanding of how to work closely with and advise senior management teams, both internally and as an outside advisor.
- Represented Iron Path Capital in a wide variety of transactions including its investments in Capitol Pain Institute, PureTech Scientific, Nalas Engineering Services, Aetherion, PRO-SET Formulated Resin Systems, VION Biosciences, TruTech Servo Motors & Systems, ClearChoiceMD and CareWell (and subsequent formation of the Emergence Health platform), and Versant Diagnostics
- Represented Ampersand Capital in a variety of transactions and ongoing portfolio company work, including the acquisitions of Cadence Fluidics and Pharma Packaging Solutions, the sales of Tjoapack to Alcami and Adaptas Solutions to IMI Plc, and investments in CurTec, P95, Biosynth, and Specac Ltd.
- Represented Enhanced Healthcare Partners in a wide variety of transactions including investments in LeadingReach and Alora Behavioral Health, the sale of PAI Pharma to Olympus Partners, and a growth investment in Vytalize Health
- Emory University School of Law, JD, with honors
- Vanderbilt University, BS, magna cum laude
- Illinois
- English
